PsychonautWiki Archive

2C-C: Difference between revisions

← Older editNewer edit →
>BronzeManul
m Undo revision 121104 by Clarity (talk)
>Unity
Restyle and expand lead. Grammatics. Add more detail to subjective effects. Sort legal status section. Add categories.
Line 2: Line 2:
{{SubstanceBox/2C-C}}
{{SubstanceBox/2C-C}}


'''4-Chloro-2,5-dimethoxyphenethylamine''' (also known as '''2C-C''') is a synthetic [[Psychoactive class::psychedelic]] substance of the [[Chemical class::phenethylamine]] chemical class and [[2C-x family]] that produces phenethylamine-type [[psychedelic]] effects when [[routes of administration|administered]].<ref>Alexander Shulgin - PIHKAL | http://www.erowid.org/library/books_online/pihkal/pihkal033.shtml</ref>  
'''4-Chloro-2,5-dimethoxyphenethylamine''' (commonly known as '''2C-C''') is a [[Psychoactive class::psychedelic]] substance of the [[Chemical class::phenethylamine]] chemical class that produces [[psychedelic]] effects when [[routes of administration|administered]].<ref>Alexander Shulgin - PIHKAL | http://www.erowid.org/library/books_online/pihkal/pihkal033.shtml</ref> It is a lesser-known member of the [[2C-x family]] of psychedelic phenethylamines, all of which were derived from the systematic modification of the [[mescaline]] molecule.


2C-C was first synthesized by Alice C. Cheng and Neal Castagnoli Jr. in 1983 as an intermediate in a study evaluating the neurotoxicity of 6-hydroxydopamine analogs <ref>Synthesis and physicochemical and neurotoxicity studies of 1-(4-substituted-2,5-dihydroxyphenyl)-2-aminoethane analogs of 6-hydroxydopamine. Alice C. Cheng and Neal Castagnoli Jr. Journal of Medicinal Chemistry 1984 27 (4), 513-520; DOI: 10.1021/jm00370a014 (acs.org) | http://pubs.acs.org/doi/abs/10.1021/jm00370a014</ref> and later investigated and described by [[Alexander Shulgin]] in his book [[PiHKAL]] ("Phenethylamines I Have Known and Loved").
2C-C was first synthesized by Alice C. Cheng and Neal Castagnoli Jr. in 1983 as an intermediate in a study evaluating the neurotoxicity of 6-hydroxydopamine analogs.<ref>Cheng, A. C., & Castagnoli Jr, N. (1984). Synthesis and physicochemical and neurotoxicity studies of 1-(4-substituted-2, 5-dihydroxyphenyl)-2-aminoethane analogs of 6-hydroxydopamine. Journal of medicinal chemistry, 27(4), 513-520. https://doi.org/10.1021/jm00370a014</ref> Its activity in humans was later investigated and documented by [[Alexander Shulgin]] in his book [[PiHKAL]] ("Phenethylamines I Have Known and Loved").  


Many users report that the effects of 2C-C are gentler, more relaxed, and [[Sedation|sedating]] than other closely related [[psychedelic]] [[phenethylamines]] such as [[2C-B]], [[2C-I]], and [[2C-E]].
Many users report that the effects of 2C-C are gentler, more relaxed, and [[Sedation|sedating]] than other closely related [[psychedelic]] [[phenethylamines]] such as [[2C-B]], [[2C-I]], and [[2C-E]]. It is considered to be one of the least potent members of the 2C-x family, with muted visual effects and a relatively unaltered headspace.


Today, it is used as a [[recreational drug use|recreational drug]] and [[entheogen]], is rarely sold on the streets and almost exclusively obtained as a grey area [[research chemical]] via online vendors. It is relatively uncommon and has only a short history of human use.
Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-C, and its history of human use is limited. Today, it is used for [[recreational drug use|recreational]] and therapeutic purposes. It is rarely sold on the streets and almost distributed online as a grey area [[research chemical]].  


==Chemistry==
==Chemistry==
Line 16: Line 16:
==Pharmacology==
==Pharmacology==
{{Further|Serotonergic psychedelic}}
{{Further|Serotonergic psychedelic}}
2C-C's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive.
2C-C's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the [[psychedelic]] experience remains the subject of ongoing scientific investigation.


==Subjective effects==
==Subjective effects==
Line 23: Line 23:


|{{effects/physical|
|{{effects/physical|
*'''[[Effect::Stimulation]]''' & '''[[Effect::Sedation]]''' - In terms of its effects on the physical energy levels of the user, the 2C-C experience typically begins with mild stimulation, but usually becomes very sedating as the experience progresses and lacks the distinctive energetic feeling associated with most [[phenethylamines]]. This feeling was accurately described in [[Alexander Shulgin]]'s PiHKAL as "''an intense form of relaxation.''"<ref name="isomer">2,5-Dimethoxy-4-chlorophenethylamine (Isomer Design / PiHKAL) | http://isomerdesign.com/PiHKAL/read.php?id=22</ref>
*'''[[Effect::Stimulation]]''' & '''[[Effect::Sedation]]''' - In terms of its effects on the physical energy levels of the user, the 2C-C experience typically begins with mild stimulation, but usually becomes somewhat sedating as the experience progresses and lacks the distinctive energetic feeling associated with most [[phenethylamines]]. This is described in [[PiHKAL]] as "''an intense form of relaxation.''"<ref name="isomer">2,5-Dimethoxy-4-chlorophenethylamine (Isomer Design / PiHKAL) | http://isomerdesign.com/PiHKAL/read.php?id=22</ref>
*'''[[Effect::Spontaneous physical sensations]]''' -  The "body high" of 2C-C can be described as a pleasurable, warm, soft, all-encompassing and mild tingling sensation. This maintains a consistent presence that steadily rises with the onset and hits its limit once the peak has been reached.
*'''[[Effect::Spontaneous physical sensations]]''' -  The "body high" of 2C-C can be described as a pleasurable, warm, soft, all-encompassing and mild tingling sensation. This maintains a consistent presence that steadily rises with the onset and hits its limit once the peak has been reached.
*'''[[Effect::Tactile enhancement]]'''
*'''[[Effect::Tactile enhancement]]'''
*'''[[Effect::Bodily control enhancement]]''' - Whilst at lower doses one may find that their bodily control is enhanced, at higher dosages this becomes suppressed.
*'''[[Effect::Bodily control enhancement]]''' - Whilst at lower doses one may find that their bodily control is enhanced, at higher dosages this becomes suppressed.
*'''[[Effect::Temperature regulation suppression]]'''
*'''[[Effect::Temperature regulation suppression]]'''
*'''[[Effect::Increased heart rate]]'''
*'''[[Effect::Increased heart rate]]'''{{citation needed}}
*'''[[Effect::Nausea]]''' -  Although nausea remains present, in comparison to other [[phenethylamines]] such as [[2C-E]], [[2C-I]] or [[2C-B]], this remains extremely mild and dissipates quickly even with higher dosages. It is perhaps one of the most physically underwhelming [[psychedelics]] out there for this reason.
*'''[[Effect::Nausea]]''' -  Although nausea remains present, in comparison to other [[phenethylamines]] such as [[2C-E]], [[2C-I]] or [[2C-B]], this remains relatively mild and tends to dissipate quickly. It is considered by some to be one of the most physically understated [[psychedelics]] known.
*'''[[Effect::Dehydration]]'''
*'''[[Effect::Pupil dilation]]'''
*'''[[Effect::Pupil dilation]]'''
*'''[[Effect::Teeth grinding]]''' - This component can be considered to be less intense when compared with that of [[MDMA]].


}}
}}
Line 45: Line 47:


====Hallucinatory states====
====Hallucinatory states====
2C-C produces a full range of high-level hallucinatory states in a fashion that is more consistent and reproducible than that of many other commonly used psychedelics. This holds particularly true in comparison to other substances within the [[phenethylamines|phenethylamine]] family. These effects include:
2C-C can produce a full range of hallucinatory states in a fashion that is more consistent and reproducible than that of many other commonly used psychedelics. However, the dose required to reach this state is significantly higher than many related 2C-x phenethylamines. These effects include:


*'''[[Effect::Transformations]]'''
*'''[[Effect::Transformations]]'''
*'''[[Effect::Internal hallucinations]]''' (''[[Effect::autonomous entities]]''; ''[[Effect::settings, sceneries, and landscapes]]''; ''[[Effect::alterations in perspective]]'' and ''[[Effect::scenarios and plots]]'') - In comparison to other psychedelics such as [[LSD]], 2C-C is extremely high in hallucinations embedded within visual geometry. This particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They are more common within dark environments and can be described as internal in their manifestation, lucid in believability, interactive in style and almost exclusively of a personal, religious, spiritual, science-fiction, fantasy, surreal, nonsensical or transcendental nature in their overall theme.
*'''[[Effect::Internal hallucinations]]''' (''[[Effect::autonomous entities]]''; ''[[Effect::settings, sceneries, and landscapes]]''; ''[[Effect::alterations in perspective]]'' and ''[[Effect::scenarios and plots]]'') - 2C-C is capable of producing high levels of hallucinogenic imagery, although typically only at very heavy doses. When this effect does occur, it commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They are more common within dark environments and can be described as internal in their manifestation, lucid in believability, interactive in style and almost exclusively of a personal, religious, spiritual, science-fiction, fantasy, surreal, nonsensical or transcendental nature in theme.
*'''[[Effect::External hallucinations]]''' (''[[Effect::autonomous entities]]''; ''[[Effect::settings, sceneries, and landscapes]]''; ''[[Effect::alterations in perspective]]'' and ''[[Effect::scenarios and plots]]'') -  2C-C is capable of external hallucinations embedded within visual geometry. This particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They can be described as external in their manifestation, lucid in believability, interactive in style and almost exclusively of a personal, religious, spiritual, science-fiction, fantasy, surreal, nonsensical or transcendental nature in their overall theme.
*'''[[Effect::External hallucinations]]''' (''[[Effect::autonomous entities]]''; ''[[Effect::settings, sceneries, and landscapes]]''; ''[[Effect::alterations in perspective]]'' and ''[[Effect::scenarios and plots]]'') -  2C-C is capable of external hallucinations embedded within visual geometry. This particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They can be described as external in their manifestation, lucid in believability, interactive in style and almost exclusively of a personal, religious, spiritual, science-fiction, fantasy, surreal, nonsensical or transcendental nature in their overall theme.


Line 55: Line 57:
The head space of 2C-C is described by many as one which is both insightful and relatively normal in its thought processes even at moderate to high dosages.
The head space of 2C-C is described by many as one which is both insightful and relatively normal in its thought processes even at moderate to high dosages.


*'''[[Effect::Empathy, affection, and sociability enhancement]]''' - This component is consistently manifested only in the context of social settings in which one is within the company of others. These feelings of sociability, love and empathy are a little weaker and less sharp than those found on substances such as [[MDMA]] and [[2C-B]]. They primarily manifest during the stimulating onset of the experience and dissipate once the full extent of the experience takes place.
*'''[[Effect::Empathy, affection, and sociability enhancement]]''' - This component is consistently manifested only in the context of social settings in which one is within the company of others. These feelings of sociability, love and empathy are not as pronounced than those found on substances such as [[MDMA]] or [[2C-B]]. They primarily manifest during the stimulating onset of the experience and dissipate during the peak and offset.
*'''[[Effect::Analysis enhancement]]'''
*'''[[Effect::Analysis enhancement]]'''
*'''[[Effect::Conceptual thinking]]'''
*'''[[Effect::Conceptual thinking]]'''
Line 62: Line 64:
*'''[[Effect::Increased music appreciation]]'''
*'''[[Effect::Increased music appreciation]]'''
*'''[[Effect::Increased libido]]'''
*'''[[Effect::Increased libido]]'''
*'''[[Effect::Memory suppression]]'''
*'''[[Effect::Memory suppression]]''' - Relative to other psychedelics, 2C-C does not produce this effect except at high doses.
**'''[[Effect::Ego death]]'''
**'''[[Effect::Ego death]]''' - Relative to other psychedelics, 2C-C does not produce this effect except at high doses.
*'''[[Effect::Mindfulness]]
*'''[[Effect::Mindfulness]]
*'''[[Effect::Novelty enhancement]]'''
*'''[[Effect::Novelty enhancement]]'''
Line 74: Line 76:
}}
}}
{{effects/auditory|
{{effects/auditory|
*'''[[Effect::Auditory enhancement|Enhancements]]'''
*'''[[Effect::Auditory enhancement]]'''
*'''[[Effect::Auditory distortion|Distortions]]'''
*'''[[Effect::Auditory distortion]]''' - This effect does not typically occur except at very high doses.
*'''[[Effect::Auditory hallucinations|Hallucinations]]'''
*'''[[Effect::Auditory hallucinations]]''' - This effect does not typically occur except at very high doses.


}}
}}
{{effects/transpersonal|
{{effects/transpersonal|


*'''[[Effect::Unity and interconnectedness]]'''
*'''[[Effect::Unity and interconnectedness]]''' - In contrast to some other psychedelics, this effect does not typically occur except at very high doses.
}}
}}
}}
}}
Line 90: Line 92:
==Toxicity and harm potential==
==Toxicity and harm potential==
{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}
{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}
The toxicity and long-term health effects of recreational 2C-C use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown. Anecdotal evidence from people who have tried 2C-C within the community suggests that there are [[Toxicity::no negative health effects attributed to trying this substance]], but nothing can be completely guaranteed.
The toxicity and long-term health effects of recreational 2C-C use do not appear to have been studied in any scientific context and the exact [[Toxicity::toxic dose is unknown]]. This is because 2C-C is a [[research chemical]] with a limited history of human use.  
 
Anecdotal reports from those who have tried this compound suggest that there are no negative health effects attributed to simply trying the substance by itself at low to moderate doses and using it very sparingly (although nothing can be completely guaranteed). [https://www.google.com/ Independent research] should always be conducted to ensure that a combination of two or more substances is safe before consumption.  


It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this substance.
It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this substance.


===Tolerance and addiction potential===
===Tolerance and addiction potential===
2C-C is [[Addiction potential::not habit-forming]] and the desire to use it can actually decrease with use. It is most often self-regulating.  
Although no formal studies have been conducted, it is not unreasonable to assume that like psychedelics in general, 2C-C is [[Addiction potential::not habit-forming]] and that the desire to use it can actually decrease with use.  


Tolerance to the effects of 2C-C are built [[Time to full tolerance::almost immediately after ingestion]]. After that, it takes about [[Time to half tolerance::3 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::7 days]] to be back at baseline (in the absence of further consumption). 2C-C presents cross-tolerance with [[Cross-tolerance::all [[psychedelic]]s]], meaning that after the consumption of 2C-C all psychedelics will have a reduced effect.
Tolerance to the effects of 2C-C are built [[Time to full tolerance::almost immediately after ingestion]]. After that, it takes about [[Time to half tolerance::3 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::7 days]] to be back at baseline (in the absence of further consumption). 2C-C presents cross-tolerance with [[Cross-tolerance::all [[psychedelic]]s]], meaning that after the consumption of 2C-C all psychedelics will have a reduced effect.
Line 103: Line 107:


*'''[[Tramadol]]''' - Tramadol lowers the seizure threshold<ref>Talaie, H., Panahandeh, R., Fayaznouri, M. R., Asadi, Z., & Abdollahi, M. (2009). Dose-independent occurrence of seizure with tramadol. Journal of medical toxicology, 5(2), 63-67. doi:10.1007/BF03161089</ref> and [[psychedelics]] may act as triggers for seizures, particularly in those who are predisposed to them.{{citation needed}}
*'''[[Tramadol]]''' - Tramadol lowers the seizure threshold<ref>Talaie, H., Panahandeh, R., Fayaznouri, M. R., Asadi, Z., & Abdollahi, M. (2009). Dose-independent occurrence of seizure with tramadol. Journal of medical toxicology, 5(2), 63-67. doi:10.1007/BF03161089</ref> and [[psychedelics]] may act as triggers for seizures, particularly in those who are predisposed to them.{{citation needed}}
*'''[[Stimulants]]''' - Stimulants affect many parts of the brain. Combined with psychedelics, stimulation can turn into uncontrollable [[anxiety]], [[Panic attacks|panic]], [[thought loops]] and [[paranoia]]. This interaction may cause elevated risk of psychosis.{{citation needed}}
*'''[[Stimulants]]''' - Combining stimulants with psychedelics may induce states of uncontrollable [[anxiety]], over-stimulation, [[thought loops]], and increase the risk of psychosis.<ref>Tripsit Factsheets - LSD | http://drugs.tripsit.me/lsd</ref>
*'''[https://en.wikipedia.org/wiki/Lithium_(medication) Lithium]''' - Lithium is often used as treatment for bipolar disorder. It may possibly cause elevated risk of seizures and psychosis due to its [[Glutamate|glutaminergic]] and [[GABA|GABAergic]] effects.{{citation needed}}
*'''[https://en.wikipedia.org/wiki/Lithium_(medication) Lithium]''' - Lithium is often used as treatment for bipolar disorder. It may possibly cause elevated risk of seizures and psychosis due to its [[Glutamate|glutaminergic]] and [[GABA|GABAergic]] effects.{{citation needed}}


==Legality==
==Legal status==
*'''Brazil''' - Possession, production and sale is illegal as it is listed on Portaria SVS/MS nº 344.<ref>http://portal.anvisa.gov.br/documents/10181/3115436/%281%29RDC_130_2016_.pdf/fc7ea407-3ff5-4fc1-bcfe-2f37504d28b7</ref>
*'''United States:''' 2C-C is listed in Schedule I of section 202(c) of the Controlled Substances Act in the United States. This was signed into law as of July 2012 under the Food and Drug Administration Safety and Innovation Act.<ref>S. 3187: Food and Drug Administration Safety and Innovation Act, Subtitle D-Synthetic Drugs | http://www.govtrack.us/congress/bills/112/s3187/text</ref>
*'''United Kingdom''' - 2C-C is a Class A drug in the United Kingdom as a result of the phenethylamine catch-all clause.<ref>United Kingdom. (1977). Misuse of Drugs Act 1971 (S.I. 1977/1243). London: The Stationery Office Limited. Retrieved July 5, 2017, from http://www.legislation.gov.uk/uksi/1977/1243/made</ref>
*'''Sweden:''' 2C-C is classified as a health hazard as of March 1, 2005 in the regulation SFS 2005:26, making it illegal to sell or possess.<ref>Svensk författningssamling | http://www.notisum.se/rnp/sls/sfs/20050026.pdf</ref>
*'''Japan:''' 2C-C is controlled by the Pharmaceutical Affairs Law in Japan, making it illegal to possess or sell.<ref>Analytical Data of Designated Substances (Shitei-Yakubutsu) Controlled by the Pharmaceutical AŠairs Law in Japan, Part I: GC-MS and LC-MS | https://www.erowid.org/references/texts/show/7395docid7635</ref>
*'''Australia:''' Australia has a blanket ban over all substituted phenethylamines including the entire 2C-X family.<ref>New Psychoactive Substances (National Drug and Alcohol Research Centre 2014) | https://comorbidity.edu.au/sites/default/files/cre/page/New%20Psychoactive%20Substances.pdf</ref>
*'''Australia:''' Australia has a blanket ban over all substituted phenethylamines including the entire 2C-X family.<ref>New Psychoactive Substances (National Drug and Alcohol Research Centre 2014) | https://comorbidity.edu.au/sites/default/files/cre/page/New%20Psychoactive%20Substances.pdf</ref>
*'''Brazil:''' Possession, production and sale is illegal as it is listed on Portaria SVS/MS nº 344.<ref>http://portal.anvisa.gov.br/documents/10181/3115436/%281%29RDC_130_2016_.pdf/fc7ea407-3ff5-4fc1-bcfe-2f37504d28b7</ref>
*'''Canada:''' 2C-C would be considered Schedule III as it is a derivative of 2,5-dimethoxyphenethylamine.<ref>Controlled Drugs and Substances Act (S.C. 1996, c. 19) |http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-12.html#h-28</ref>
*'''China:''' As of October 2015 2C-C is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>
*'''Germany''': On December 13, 2014 2C-C was added to the controlled substance act ("BtMG"), making it illegal to produce, sell or possess.<ref>Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften (28. BtMÄndV)| http://www.buzer.de/gesetz/11392/a189949.htm</ref>
*'''Germany''': On December 13, 2014 2C-C was added to the controlled substance act ("BtMG"), making it illegal to produce, sell or possess.<ref>Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften (28. BtMÄndV)| http://www.buzer.de/gesetz/11392/a189949.htm</ref>
*'''Japan:''' 2C-C is controlled by the Pharmaceutical Affairs Law in Japan, making it illegal to possess or sell.<ref>Analytical Data of Designated Substances (Shitei-Yakubutsu) Controlled by the Pharmaceutical AŠairs Law in Japan, Part I: GC-MS and LC-MS | https://www.erowid.org/references/texts/show/7395docid7635</ref>
*'''Latvia:''' 2C-C is a Schedule I controlled substance.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (2,5-Dimetoksifeniletānamīni) | http://likumi.lv/doc.php?id=121086</ref>
*'''Latvia:''' 2C-C is a Schedule I controlled substance.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (2,5-Dimetoksifeniletānamīni) | http://likumi.lv/doc.php?id=121086</ref>
*'''Sweden:''' 2C-C is classified as a health hazard as of March 1, 2005 in the regulation SFS 2005:26, making it illegal to sell or possess.<ref>Svensk författningssamling | http://www.notisum.se/rnp/sls/sfs/20050026.pdf</ref>
*'''Switzerland:''' Possession, production and sale is illegal.<ref>http://web.archive.org/web/20170329020935/https://www.admin.ch/opc/de/classified-compilation/20101220/index.html</ref>
*'''Switzerland:''' Possession, production and sale is illegal.<ref>http://web.archive.org/web/20170329020935/https://www.admin.ch/opc/de/classified-compilation/20101220/index.html</ref>
*'''China''' - As of October 2015 2C-C is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>
*'''United Kingdom:''' 2C-C is a Class A drug in the United Kingdom as a result of the phenethylamine catch-all clause.<ref>United Kingdom. (1977). Misuse of Drugs Act 1971 (S.I. 1977/1243). London: The Stationery Office Limited. Retrieved July 5, 2017, from http://www.legislation.gov.uk/uksi/1977/1243/made</ref>
*'''Canada:''' 2C-C would be considered Schedule III as it is a derivative of 2,5-dimethoxyphenethylamine.<ref>Controlled Drugs and Substances Act (S.C. 1996, c. 19) |http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-12.html#h-28</ref>
*'''United States:''' 2C-C is listed in Schedule I of section 202(c) of the Controlled Substances Act in the United States. This was signed into law as of July 2012 under the Food and Drug Administration Safety and Innovation Act.<ref>S. 3187: Food and Drug Administration Safety and Innovation Act, Subtitle D-Synthetic Drugs | http://www.govtrack.us/congress/bills/112/s3187/text</ref>


==See also==
==See also==
*[[Responsible use]]
*[[Responsible use]]
**[[Volumetric dosing]]
*[[Psychedelic]]
*[[Psychoactive substance index]]
*[[Phenethylamine]]
*[[Psychedelics]]
*[[Phenethylamines]]
*[[2C-x]]
*[[2C-x]]
*[[25C-NBOMe]]
*[[25C-NBOMe]]
Line 132: Line 134:
*[https://erowid.org/chemicals/2cc/2cc.shtml 2C-C (Erowid Vault)]
*[https://erowid.org/chemicals/2cc/2cc.shtml 2C-C (Erowid Vault)]
*[https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=22 2C-C (PiHKAL / Isomer Design)]
*[https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=22 2C-C (PiHKAL / Isomer Design)]
===Community===
*[http://www.bluelight.org/vb/threads/286447-The-Big-amp-Dandy-2C-C-Thread 2C-C (Bluelight)]
*[http://www.bluelight.org/vb/threads/286447-The-Big-amp-Dandy-2C-C-Thread 2C-C (Bluelight)]
*[http://disregardeverythingisay.com/post/109207440089/2c-c-broken-down-and-described 2C-C (Disregard Everything I Say)]
*[http://disregardeverythingisay.com/post/109207440089/2c-c-broken-down-and-described 2C-C (Disregard Everything I Say)]
Line 138: Line 141:
<references/>
<references/>
{{#set:Featured=true}}
{{#set:Featured=true}}
[[Category:Research chemical]]
[[Category:Psychoactive substance]]
[[Category:Psychoactive substance]]
[[Category:Phenethylamine]]
[[Category:Phenethylamine]]
[[Category:Psychedelic]]
[[Category:Psychedelic]]
[[Category:Hallucinogen]]
Retrieved from "http://psy.st/wiki/2C-C"